Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 2,300.00
-25.00 (-1.08%)
Aug 15, 2025, 5:15 PM GMT+1
Bioventix Market Cap
Bioventix has a market cap or net worth of 120.17 million as of August 15, 2025. Its market cap has decreased by -47.38% in one year.
Market Cap
120.17M
Enterprise Value
115.03M
Revenue
13.66M
Ranking
n/a
PE Ratio
15.53
Stock Price
2,300.00
Market Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 120.17M, an increase of 1,120.33%. That is a compound annual growth rate of 17.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 120.17M | -27.49% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | 228.43M | 34.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.46B |
| GSK plc | 57.85B |
| Haleon | 32.21B |
| Smith & Nephew | 11.81B |
| ConvaTec Group | 4.73B |
| Hikma Pharmaceuticals | 4.01B |
| Oxford Nanopore Technologies | 2.11B |
| HUTCHMED (China) | 2.02B |